ReviewFrontiers in neuroscience2021

Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment.

Iris J Broce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.